Chronic prostatitis.
Conditions
Interventions
Treatment group:Qianlianshuan in combination with Tamsulosin Hydrochloride Extended-release Capsules.
Control group:Tamsulosin Hydrochloride Extended-release Capsules
Sponsors
Henan Provincial Hospital of Traditional Chinese Medicine (Second Affiliated Hospital of Henan University of Traditional Chinese Medicine)
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Age between 18 and 50 years old; (2) Meeting the Western medical diagnostic criteria for type IIIB prostatitis; (3) Syndrome differentiation in Traditional Chinese Medicine consistent with damp-heat obstruction and blood stasis; (4) NIH-CPSI total score between 15 and 43 inclusive; (5) Disease course of more than 3 months; (6) Those who have received other treatments before the trial must discontinue any medication for at least 2 weeks;
Exclusion criteria
Exclusion criteria: (1) Patients with allergic constitution allergy to this medication or those who cannot tolerate the drug; (2) Those with concurrent urinary tract infections acute prostatitis prostate hyperplasia urinary system stones urethral stricture prostate cancer or other diseases; (3) Patients with severe heart brain blood vessel diseases liver kidney dysfunction hypotension mental illness or other diseases; (4) Those who plan to conceive during the medication period or within 1 month after the end of medication; (5) Individuals who have participated in other clinical trials within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prostate fluid levels of inflammatory cytokines (TNF-a IL-8 IL-1ß);Pain scoring;Prostatic fluid lecithin body count; | — |
Countries
China
Contacts
Public ContactYucong Jia
Henan Provincial Hospital of Traditional Chinese Medicine (Second Affiliated Hospital of Henan University of Traditional Chinese Medicine)
Outcome results
None listed